Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells is a research paper published in Science Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL149741
NIAID NIH HHS
Grant: T32 AI007405
NCATS NIH HHS
Grant: UL1 TR002535
NHLBI NIH HHS
Grant: K08 HL155894
NIAID NIH HHS
Grant: R56 AI155729
NIAID NIH HHS
Grant: F32 AI161790
NIDDK NIH HHS
Grant: P30 DK116073
NHLBI NIH HHS
Grant: R01 HL130938
NHLBI NIH HHS
Grant: R35 HL140039
FWCI
2.12
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD)
Additional file 1 of Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD)